Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com

FDA, Duke University Planning Epinephrine Access Workshop for December

ByPatrick Lavery

November 24th 2025

speech bubbles concept 3d illustration | Image Credit: © frender - stock.adobe.com - modified in Canva by Chris Cole, PharmTech.

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II

ByChristopher Cole

November 24th 2025

FAQ: Key AI Applications in Drug Development

ByPatrick Lavery

November 21st 2025

speech bubbles concept 3d illustration | Image Credit: © frender - stock.adobe.com

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part I

ByChristopher Cole

November 21st 2025

PharmTech Weekly News Roundup — Week of November 17, 2025

ByPatrick Lavery

November 21st 2025

May 2003

Articles in this issue

Newsletter

Related Content

FDA, Duke University Planning Epinephrine Access Workshop for December

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II

FAQ: Key AI Applications in Drug Development

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part I

PharmTech Weekly News Roundup — Week of November 17, 2025

Trending on Pharmaceutical Technology

FAQ: Key AI Applications in Drug Development

FDA, Duke University Planning Epinephrine Access Workshop for December

How ten23 health is Advancing Patient-Centric Drug Delivery

Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II

METHONOVA™: Enhancing Cell Culture Growth and Productivity with High Purity Methylcellulose